<DOC>
	<DOC>NCT00908778</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of Vitreosolve® in diabetic retinopathy patients.</brief_summary>
	<brief_title>A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Vitreous Detachment</mesh_term>
	<criteria>Subjects with a history of systemic diabetes(type I,or II) Subject with a documented history of Non proliferative Diabetic Retinopathy(NPDR) Subjects with no or partial PVD at baseline exam in study eye. Subjects with retinal pathology in the study eye other then (NPDR) Subjects with high myopia in the study eye Subjects who have monocular vision or central lateral vision of 20/200 or worse BCVA in the nonstudy eye. Subjects with an aphakic study eye or if pseudophakic, cataract extraction surgery less then 6 months prior to study enrollment. Subjects that have either vitrectomy surgery, intavitreal injections, or laser treatments in the study eye.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Diabetic Retinopathy</keyword>
</DOC>